


The Fund's sole aim is capital growth by investing principally in the equities of UK companies with high growth potential. Income considerations are ignored.
| Name | % Net Assets |
|---|---|
| BP | 8.6% |
| HSBC | 6.7% |
| Royal Dutch Shell | 6.6% |
| Vodafone Group | 4.4% |
| BAT | 4.3% |
| GlaxoSmithKline | 4.1% |
| Tesco | 3.6% |
| BG | 3.6% |
| AstraZeneca | 3.0% |
| Reckitt Benckiser | 2.8% |
| Key | % Net Assets |
|---|---|
| 8.6% | |
| 6.7% | |
| 6.6% | |
| 4.4% | |
| 73.7% |
| Date | 23-Jun-2022 |
|---|---|
| NAV | 4,586.82p |
| Currency | GBP |
| Change | 57.36p |
| % | 1.27% |
| YTD change | 4,586.82p |
| YTD % | n/a |
| Fund Inception | 17/12/1968 |
|---|---|
| Fund Manager | Simon Murphy |
| TER | 1.66 (30-Nov-2013) |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | £10 |
| Savings | £10 |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.06 |
You are here: research